Juan Andres - 18 Aug 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Technical Operations and Quality Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 18 Aug 2021
Net transactions value: -$1,973,950
Form type: 4
Filing time: 20 Aug 2021, 09:17:21 UTC
Previous filing: 18 Aug 2021
Next filing: 24 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$61,050	+5,000		$12.21^*	5,000	18 Aug 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	$2,035,000	-5,000	-100%	$407.00	0	18 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-1.5%	$0.000000	339,822	18 Aug 2021	Common Stock	5,000	$12.21	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
F2	25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

Remarks:

Chief Technical Operations and Quality Officer